CoChat

Positive allosteric modulators of the μ‐opioid receptor: a novel approach for future pain medications

Open access
Burford, N T, Traynor, J R, Alt, A · 2015 · British Journal of Pharmacology
Cited by 112

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Morphine and other agonists of the μ‐opioid receptor are used clinically for acute and chronic pain relief and are considered to be the gold standard for pain medication. However, these opioids also have significant side effects, which are also mediated via activation of the μ‐opioid receptor. Since the latter half of the twentieth century, researchers have sought to tease apart the mechanisms underlying analgesia, tolerance and dependence, with the hope of designing drugs with fewer side effects. These efforts have revolved around the design of orthosteric agonists with differing pharmacokinetic properties and/or selectivity profiles for the different opioid receptor types. Recently, μ‐opioid receptor‐positive allosteric modulators (μ‐ PAMs ) were identified, which bind to a (allosteric) site on the μ‐opioid receptor separate from the orthosteric site that binds an endogenous agonist. These allosteric modulators have little or no detectable functional activity when bound to the receptor in the absence of orthosteric agonist, but can potentiate the activity of bound orthosteric agonist, seen as an increase in apparent potency and/or efficacy of the orthosteric agonist. In this review, we describe the potential advantages that a μ‐ PAM approach might bring to the design of novel therapeutics for pain that may lack the side effects currently associated with opioid therapy. Linked Articles: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12599

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 112

Metadata

Authors
Burford, N. T., Traynor, J. R., & Alt, A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-07
Volume
172
Issue
2
Pages
277-286
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1922816396
Cited by
112
References
10
FWCI
3.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Positive allosteric modulators of the μ‐opioid receptor: a novel approach for future pain medications. https://app.cochat.ai/papers/10.1111/bph.12599
The paper
Burford, N. T., Traynor, J. R., & Alt, A. (2015). Positive allosteric modulators of the μ‐opioid receptor: a novel approach for future pain medications. British Journal of Pharmacology. https://doi.org/10.1111/bph.12599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.